A recent petition for cert addresses the question of what, if any, recourse is available to a patentee against the United States for infringed method claims, where some or all of the method steps are carried out in another country, but the product of that process is imported into the US. In addition, the petition […]
If you or a colleague will be attending BIO 2007 in Boston, we’d like to invite you to join us for a breakfast seminar featuring four of Ohio’s premiere bioscience research institutions. The breakfast event, entitled “Partnering with Ohio’s World-Class Research Institutions” is scheduled for Monday, May 7 from 7:45am-9:15am at M.J. O’Connor’s Irish Pub, next […]
After Abbott Laboratories announced that it would not launch new medicines in Thailand in response to the military-installed government’s decision not to honor the company’s patent for its AIDS drug, the company has now announced a new plan. Abbott and World Health Organization (WHO) Director-General, Margaret Chan, have agreed on a neew approach to provide […]
Abbott Laboratories announced that it will not launch new medicines in Thailand in response to the military-installed government’s decision not to honor the company’s patent for an AIDS drug. On January 29th 2007 the Thai Ministry of Public Health announced that it would issue compulsory licenses for Kaletra and for Plavix, an anti-platelet medication that […]
It was three up and three down for the Wisconsin Alumni Research Foundation (WARF) as the U.S. Patent and Trademark Office (USPTO) rejected the claims of its patents on human embryonic stem cells. Embryonic stem cells, as their name suggests, are derived from embryos that develop from eggs that have been fertilized in vitro. Embryonic stem cells […]
A reader on Philip Brooks’ Patent Infringement Updates asked about the downstream effects of the CAFC decision invalidating Pfizer’s Norvasc® patent (U.S. Patent No. 4,879,303). In this appeal, the CAFC held that the district court erred in holding that the subject matter of claims 1-3 of the ’303 patent would not have been obvious. Pfizer, […]
I have been tagged by Colin Samuels of the Infamy or Praise blog to continue a meme-tag that has been circulating about. Actually, I was tagged a bit ago but am just catching up on some loose ends. OK, in the interest of collegiality, here are five things you probably didn’t know about me: I have a […]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
